by In2Pharma | Mar 1, 2023 | News
Luxembourg IML, the association of the innovative pharmaceutical industry in Luxembourg has revised and updated their Code of Ethics. The proposed amendments will be submitted for approval at the General Assembly to be held on 17 April 2023. Here below you can find a...
by In2Pharma | Dec 15, 2022 | News
Luxembourg There has been an update on: New instructions for the preparation and submission of additional risk minimisation material (aRMM) for evaluation and approval in Luxembourg: update contact detail adverse event reportingupdate address to send the printed...
by In2Pharma | Feb 17, 2022 | News
Luxembourg APL, the Association Pharmaceutique Luxembourgeoise, is a Luxembourg-based association founded in 2011. The APL’s mission is to promote better healthcare by encouraging therapeutic innovation in the field of medicines for human use in Luxembourg. It...
by In2Pharma | Oct 25, 2021 | News
Luxembourg The Luxembourg national competent authority Division de la Pharmacie et des Médicaments de la Direction de la Santé has published 2 new documents. Instructions for marketing authorization holders for preparation and submission of additional risk...
by In2Pharma | Nov 4, 2019 | News
Luxembourg Le Ministère de la Santé of Luxembourg reminds all MAHs to notify to the Minister of Health in cases of temporary or permanent interruption of the placing on the market for the medicinal product no later than two months before this interruption and inform...
